Appili Therapeutics, Inc. (APLIF)
0.0142
0.00 (0.00%)
USD |
OTCM |
Feb 20, 16:00
Appili Therapeutics EPS Diluted (Quarterly) : -0.0053 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.2819 |
| Lexaria Bioscience Corp. | -0.0746 |
| Xenon Pharmaceuticals, Inc. | -1.147 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.681M |
| Revenue (Quarterly) | 0.0825M |
| Total Expenses (Quarterly) | 0.7634M |
| Enterprise Value | 10.66M |
| Profit Margin (Quarterly) | -825.5% |
| Earnings Yield | -121.1% |
| Normalized Earnings Yield | -121.83 |